Thursday, September 10, 2026
Biotech

Drug Costs May Rise With New Tariff Idea

A drug company leader says new tariffs on generic medicines could make drug prices higher for American patients.

Patients in America could pay more for common medicines. That is the warning from Richard Saynor, the head of Sandoz. Sandoz makes many affordable generic drugs. Former President Trump suggests new taxes on imported generic drugs. These taxes are called tariffs.

Saynor worries about what these tariffs could do. Drug companies might need to charge more for their medicines. They might even stop selling some drugs in the U.S. This could make it harder for people to get the drugs they need. It could also make life-saving medicines more expensive.

Generic drugs are very important for many people. They are cheaper versions of brand-name drugs. They help millions afford their health care. New tariffs would mean these affordable options are no longer affordable. This could create big problems for patients and their wallets.

Source: CNBC

#Biotech#Healthcare#Tariffs#Generic Drugs

More from Biotech